MedPath

Olympic Ophthalmics, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:0

Trial Phases

3 Phases

Phase 1:1
Phase 4:2
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (50.0%)
Not Applicable
1 (25.0%)
Phase 1
1 (25.0%)

A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation

Phase 1
Recruiting
Conditions
MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye Syndrome
First Posted Date
2024-02-01
Last Posted Date
2024-02-01
Lead Sponsor
Olympic Ophthalmics, Inc.
Target Recruit Count
200
Registration Number
NCT06235450
Locations
🇺🇸

Olympic Ophthalmics, Issaquah, Washington, United States

Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients

Phase 4
Conditions
Dry Eye
First Posted Date
2022-03-31
Last Posted Date
2022-03-31
Lead Sponsor
Olympic Ophthalmics, Inc.
Target Recruit Count
30
Registration Number
NCT05304637
Locations
🇺🇸

Olympic Ophthalmics, Issaquah, Washington, United States

🇺🇸

Periman Eye Institute, Seattle, Washington, United States

A Usability Study of External Neuromodulation With iTEAR100 Generation 2

Phase 4
Conditions
Dry Eye Syndromes
First Posted Date
2022-03-31
Last Posted Date
2022-03-31
Lead Sponsor
Olympic Ophthalmics, Inc.
Target Recruit Count
100
Registration Number
NCT05304650
Locations
🇺🇸

Olympic Ophthalmics, Issaquah, Washington, United States

Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal Users

Not Applicable
Conditions
Visual Display Users With Previously Undiagnosed Dry Eye
First Posted Date
2021-02-21
Last Posted Date
2021-02-21
Lead Sponsor
Olympic Ophthalmics, Inc.
Target Recruit Count
35
Registration Number
NCT04763018
Locations
🇺🇸

Fishman Vision, Palo Alto, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.